Physically acting out vivid dreams during REM sleep, sometimes violently, due to a loss of the muscle paralysis that normally keeps the body still.
Medically reviewed by
Dr. Mihaela G.
REM Sleep Behavior Disorder (RBD) involves physically acting out vivid dreams during REM sleep, sometimes with surprising force, kicking, punching, shouting, or leaping out of bed, because the muscle paralysis that normally accompanies REM sleep, keeping the body still while the brain dreams, fails to engage properly. Under typical circumstances, REM sleep comes with a built-in safety mechanism: the body is essentially disconnected from voluntary movement, so dream content stays internal. In RBD, this mechanism breaks down, and dream content gets expressed physically.
This is genuinely different from sleepwalking. The person with RBD is dreaming, often a dream involving being chased, attacked, or defending themselves, and acting that dream out with their actual body, sometimes injuring themselves or a bed partner in the process. Unlike sleepwalking, episodes occur during the second half of the night, when REM sleep is more concentrated, and unlike sleep terrors, the person can often recall the dream content in detail if woken during or shortly after an episode.
What makes RBD particularly significant clinically, beyond the immediate safety concerns, is its strong, well-documented connection to certain neurodegenerative conditions, most notably Parkinson’s disease, that may not appear until years or even decades after RBD itself begins. This makes RBD diagnosis meaningful well beyond just managing the sleep symptoms themselves.
Acting out dream content
Physical behaviors during sleep that appear to directly correspond to dream content, including punching, kicking, shouting, jumping, or grabbing, often connected to dreams involving threat, confrontation, or being chased.
Vivid, recallable dream content
Unlike sleepwalking or sleep terrors, the person with RBD can frequently describe the dream in detail if woken during or shortly after an episode, with the physical behavior often matching what was happening in the dream.
Potential for injury
Episodes can result in genuine physical injury, either to the person themselves (from falling out of bed or striking furniture) or to a bed partner, making this one of the more safety-relevant conditions in this manual.
Occurrence in the second half of the night
Episodes characteristically occur during the second half of the sleep period, when REM sleep is more concentrated, distinguishing the timing from sleepwalking and sleep terrors, which more typically occur in the first third of the night.
Relative ease of awakening
Unlike sleepwalking or sleep terrors, a person experiencing an RBD episode can often be more easily woken, and upon waking, typically becomes oriented relatively quickly, distinct from the prolonged confusion sometimes seen with NREM arousal disorders.
⋅ Fear or distress connected to the content of the acted-out dreams, often involving threat or confrontation
⋅ Anxiety, in a bed partner, about sleeping in the same bed due to safety concerns
⋅ Embarrassment or worry about having injured oneself or someone else during an episode
⋅ Concern, once aware of the diagnosis, about its association with future neurological risk
⋅ Vivid, often detailed recall of dream content if woken during or after an episode
⋅ Relatively rapid orientation upon waking, distinct from prolonged confusion seen in other parasomnias
⋅ Limited awareness, during the episode itself, that the physical movements are actually occurring
⋅ Dream content frequently involving being chased, attacked, or needing to defend oneself
⋅ Physical movements during sleep that correspond to dream content, such as punching or kicking
⋅ Shouting, talking, or other vocalizations during episodes
⋅ Injury to oneself or a bed partner resulting from physical movements during episodes
⋅ Episodes occurring predominantly during the second half of the night
⋅ Acting out dream content with corresponding physical movements during sleep
⋅ Falling out of bed or colliding with furniture during episodes
⋅ Striking, grabbing, or otherwise physically affecting a bed partner during episodes
⋅ Relative ease of being woken compared to other parasomnias
REM Sleep Behavior Disorder affects approximately 0.5-1.25% of adults, and is considerably more common in men, particularly those over age 50, distinguishing its demographic profile notably from the NREM parasomnias, which peak in childhood with no strong gender skew.
The strongest and most clinically significant association is with neurodegenerative conditions, particularly Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. RBD that occurs without any other identifiable cause, sometimes called isolated or idiopathic RBD, is now understood to frequently represent an early, prodromal feature of one of these conditions, sometimes preceding the more recognized motor or cognitive symptoms by years to decades.
Certain medications, particularly some antidepressants, can trigger or unmask RBD-like symptoms, and this medication-related form is generally considered separately from the more concerning isolated form connected to later neurodegenerative risk.
Comorbidity with the neurodegenerative conditions mentioned above is, in many ways, the central clinical concern surrounding RBD, since longitudinal research has found that a substantial majority of people with isolated RBD eventually develop one of these conditions if followed for a sufficiently long period.
REM Sleep Behavior Disorder results from a breakdown in the brainstem circuitry responsible for REM sleep muscle paralysis, known as REM atonia, which normally prevents the body from physically acting out dream content.
Brainstem dysfunction, particularly affecting specific nuclei involved in generating REM atonia, is the direct mechanism underlying RBD. Research, including some based on examining brain tissue after death, has identified changes in these same brainstem regions that are also affected in the early stages of Parkinson’s disease and related conditions, providing a biological explanation for why RBD so often precedes these neurodegenerative conditions.
Synuclein-related neurodegeneration, the same underlying process implicated in Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy, appears to be the connecting thread in the majority of isolated RBD cases, with the brainstem circuitry controlling REM atonia apparently affected earlier in the disease process than the brain regions responsible for the more classically recognized motor and cognitive symptoms of these conditions.
Medication-induced RBD, distinct from the isolated, neurodegeneration-associated form, can occur with certain antidepressants, particularly some that affect serotonin and norepinephrine systems, and this form is generally considered to carry a different, less concerning long-term significance than isolated RBD.
Narcolepsy is also associated with RBD in some cases, reflecting a different, though still REM-sleep-related, underlying mechanism connecting the two conditions.
REM Sleep Behavior Disorder is diagnosed based on repeated episodes of arousal during sleep associated with vocalization or complex motor behaviors, occurring during REM sleep, and generally more than 90 minutes after sleep onset, more frequent during the later part of the sleep period, and rarely occurring during daytime naps. Upon awakening from these episodes, the person is rapidly alert and oriented, rather than confused. Polysomnography demonstrates REM sleep without the expected atonia, or a history strongly suggestive of RBD alongside an established synucleinopathy (such as Parkinson’s disease). The behaviors cause significant distress or risk of injury (to self or bed partner), and aren’t better explained by another sleep disorder, mental disorder, substance use, or medical condition.
Differential diagnosis requires distinguishing RBD from sleepwalking, which occurs during non-REM sleep, typically earlier in the night, with the person significantly harder to wake and showing little to no dream content recall, unlike RBD’s typical pattern of relatively easy waking with vivid, detailed dream recall. Nocturnal seizures can sometimes resemble RBD episodes and should be considered, particularly if behaviors are highly stereotyped. Given the significant association with neurodegenerative conditions, evaluation for RBD, particularly when it appears to occur in isolation without an obvious alternative cause, often includes consideration of broader neurological assessment and ongoing monitoring.
Treatment for REM Sleep Behavior Disorder focuses on safety and symptom control, alongside, when isolated RBD is identified, important consideration of longer-term neurological monitoring.
Safety measures
Modifying the sleep environment to reduce injury risk, removing sharp or hard objects near the bed, padding furniture corners, considering separate sleeping arrangements from a bed partner if episodes involve significant physical movement, is often the most immediately important intervention, regardless of what other treatment is pursued.
Melatonin
Melatonin, at doses higher than typically used for general sleep purposes, has solid evidence for reducing RBD symptom frequency and severity, and is often considered a first-line pharmacological option given its generally favorable side-effect profile compared to other options.
Clonazepam
Clonazepam, a benzodiazepine, has long-standing evidence for reducing RBD episodes, though its use requires careful consideration given general concerns about long-term benzodiazepine use, particularly in older adults, who represent the population most commonly affected by RBD.
Addressing medication-related RBD
When RBD appears connected to a specific medication, particularly certain antidepressants, working with the prescribing physician to reassess this medication, where clinically appropriate, is an important consideration.
Neurological monitoring for isolated RBD
Given the strong association with later neurodegenerative conditions, isolated RBD, occurring without another clear explanation, often warrants discussion with a neurologist about ongoing monitoring for early signs of Parkinson’s disease or related conditions, even when the RBD symptoms themselves are being adequately managed.
Prioritize a safe sleep environment immediately. Removing hazards near the bed, padding sharp furniture edges, and considering separate sleeping arrangements if episodes involve significant movement are practical, important first steps that don’t require waiting for a full treatment plan to be in place.
Take melatonin or clonazepam as prescribed, even if episodes feel manageable. Both have solid evidence for reducing RBD frequency and severity, and consistent use tends to provide more reliable protection than addressing episodes only as they occur.
Talk openly with your bed partner about the condition. Understanding that the physical movements reflect dream content, rather than any intentional action, can help reduce fear or tension in the relationship, while also supporting practical safety planning together.
If your diagnosis is isolated RBD, ask your physician about appropriate neurological follow-up. Given the documented connection to later neurodegenerative conditions, staying engaged with appropriate monitoring, even while feeling completely well otherwise, is a reasonable, informed approach to your long-term health.
Mention any new medications to your sleep specialist, particularly antidepressants. Since certain medications can trigger or worsen RBD, this connection is worth flagging clearly if your symptoms change after a medication adjustment.
The prognosis for symptom control in REM Sleep Behavior Disorder is generally good; melatonin and clonazepam both have solid evidence for reducing episode frequency and severity, and combined with appropriate safety measures, the immediate injury risk associated with the condition can be substantially reduced.
The longer-term picture is more complex, particularly for isolated RBD. Longitudinal research following people with isolated RBD over many years has found that a substantial majority eventually develop Parkinson’s disease, dementia with Lewy bodies, or a related condition, making RBD diagnosis significant well beyond the sleep symptoms alone.
This connection, while serious, also carries genuine value: identifying isolated RBD provides an opportunity for earlier awareness and monitoring, and as research into early intervention for neurodegenerative conditions continues to develop, this earlier identification may become increasingly clinically meaningful over time.
Medication-related RBD, distinct from the isolated form, generally has a more straightforward outlook, often improving or resolving with appropriate adjustment of the triggering medication, without carrying the same long-term neurological implications.
Seek evaluation if you, or a bed partner, notice physical movements, vocalizations, or behaviors during sleep that seem to correspond to dream content, particularly if they’ve resulted in injury or pose a safety concern.
Seek prompt evaluation if episodes involve significant physical force or have caused injury to yourself or a bed partner, since safety measures and appropriate treatment can substantially reduce this risk.
If diagnosed with isolated RBD, discuss appropriate neurological follow-up with your physician, given the documented connection to certain neurodegenerative conditions, even if you’re not currently experiencing any other neurological symptoms.
Someone in your life might be quietly looking for this. Share it:
These conditions share overlapping symptoms and are often misdiagnosed.
Sleepwalking occurs during deep, non-REM sleep, typically in the first third of the night, and the person is usually difficult to wake, shows little to no memory of the episode afterward, and isn’t acting out specific dream content. REM sleep behavior disorder occurs during REM sleep, typically in the second half of the night, and involves physically acting out vivid dream content, often connected to themes of threat or confrontation, with the person typically easier to wake and able to recall the dream in detail afterward.
Research has found that the same brainstem regions affected early in Parkinson’s disease and related conditions, like dementia with Lewy bodies, are also responsible for generating the muscle paralysis that normally prevents acting out dreams during REM sleep. When REM sleep behavior disorder occurs without another clear explanation, sometimes called isolated RBD, it’s now understood to frequently represent an early sign of this same underlying neurodegenerative process, often appearing years to decades before the more classically recognized symptoms of these conditions.
Not with certainty for every individual, but research following people with isolated REM sleep behavior disorder over many years has found that a substantial majority eventually develop Parkinson’s disease, dementia with Lewy bodies, or a related condition. This is a significant association, and it’s part of why isolated RBD diagnosis often includes a conversation with a neurologist about appropriate long-term monitoring, even though the timeline for any individual person, and whether progression occurs at all, can’t be predicted with complete certainty.
Treatment typically combines safety measures, such as modifying the sleep environment to reduce injury risk, with medication. Melatonin, often at higher doses than used for general sleep purposes, is commonly used as a first-line option given its favorable safety profile. Clonazepam has long-standing evidence as well, though its use requires careful consideration given general concerns about long-term benzodiazepine use, particularly in the older adult population most commonly affected by this condition. When isolated RBD is identified, ongoing neurological monitoring is often also recommended.
Schenck, C. H., Boeve, B. F., & Mahowald, M. W. (2013). Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Medicine, 14(8), 744–748. PubMed
Postuma, R. B., Iranzo, A., Hu, M., Högl, B., Boeve, B. F., Manni, R., Oertel, W. H., Arnulf, I., Ferini-Strambi, L., Puligheddu, M., Antelmi, E., Cochen De Cock, V., Arnaldi, D., Mollenhauer, B., Videnovic, A., Sonka, K., Jung, K. Y., Kunz, D., Dauvilliers, Y., … Pelletier, A. (2019). Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain, 142(3), 744–759. PubMed
St Louis, E. K., & Boeve, B. F. (2017). REM sleep behavior disorder: diagnosis, clinical implications, and future directions. Mayo Clinic Proceedings, 92(11), 1723–1736. PubMed
Aurora, R. N., Zak, R. S., Maganti, R. K., Auerbach, S. H., Casey, K. R., Chowdhuri, S., Karippot, A., Ramar, K., Kristo, D. A., & Morgenthaler, T. I. (2010). Best practice guide for the treatment of REM sleep behavior disorder (RBD). Journal of Clinical Sleep Medicine, 6(1), 85–95. PubMed
Iranzo, A., Santamaria, J., & Tolosa, E. (2016). Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurology, 15(4), 405–419. PubMed
